Still not losing weight on semaglutide at week 2? Read this first

The biggest myth: if weight hasn't dropped by week 2, something is wrong

This is the question our prescribers hear most often in the early weeks, and the reassurance is consistent: week 2 is far too early to judge anything. The misconception is understandable. You've started a medicine, you're paying attention, and the expectation is that the body should respond quickly. But semaglutide doesn't work like a stimulant or a diuretic. It changes how the brain and gut communicate about hunger and fullness, a process that builds gradually as the dose increases.

At 0.25mg, the medicine's primary purpose is to settle your system and reduce the chance of side effects when the dose rises. Appetite suppression does occur at this level for some people, but it is mild and inconsistent. This is why the licensed schedule works in monthly steps rather than starting at the full maintenance dose. If you've been reading about other people's results at four, eight or twelve weeks, it's worth visiting our page on how long Wegovy takes to work for a fuller picture of the expected timeline.

One more thing worth naming honestly: it is frustrating to wait. If you have been working hard at lifestyle changes and watching the scales not move, that frustration is legitimate. The biology hasn't caught up yet. That's different from the treatment not working.

What semaglutide is actually doing in weeks 1 and 2

Semaglutide is a GLP-1 receptor agonist. It mimics a gut hormone that signals fullness to the brain, slows how quickly food leaves the stomach, and helps regulate blood sugar. These effects are dose-dependent, meaning they strengthen as the dose increases over the titration schedule.

In the first two injections, the body is encountering the medicine for the first time. Blood levels are building but haven't yet reached a steady state at even the starting concentration. You may notice you feel slightly less hungry after certain meals, or that you feel full sooner, these are early signs the mechanism is beginning. Most people, though, notice very little at 0.25mg, and that is completely within the expected range.

There's also a practical confounding factor: digestive changes. Semaglutide slows gastric emptying, and in the first two weeks some people experience a degree of fluid retention, bloating, or irregular bowel habits that can make scale weight temporarily unreliable. What the scales show at day 14 is rarely a clean measure of fat change. The first two weeks of semaglutide in more detail covers what is and isn't typical at this stage.

When to start looking for real signals, and when to flag concerns to your prescriber

The more meaningful window to assess early appetite response is weeks 4 to 8, once the dose has increased to 0.5mg and then 1.0mg. Many people report a noticeable shift in hunger around the first dose increase, a genuine reduction in the mental noise around food, smaller portions feeling satisfying, and less impulse eating between meals. That is the signal worth looking for, not a number on week-2 scales.

Weight loss visible on scales tends to follow appetite suppression by a few weeks, particularly if lifestyle changes are already in place. If you're specifically on Wegovy and the scales haven't shifted, our page on not losing any weight on Wegovy is a useful companion read as you move through the early months, alongside the broader question of not losing weight on semaglutide.

There are some things worth raising with your prescriber early, regardless of the scales: persistent nausea that isn't improving, difficulty keeping food or fluids down, or any symptoms that concern you. The NHS patient information on semaglutide sets out the side effects to watch for and the situations that need prompt attention. If you're unsure whether what you're experiencing is typical, reaching out to your prescriber is always the right call, that's what aftercare is for.

For context on how results build over a longer horizon, the week 6 picture offers a useful comparison point for where most people start to see clearer progress. And if cost has been a factor in your thinking at any stage, the Wegovy cost guide explains what private treatment typically involves in the UK.

What you can do right now that actually helps

The evidence base for semaglutide (including the STEP 1 trial, which followed 1,961 adults over 68 weeks and is summarised in NICE's appraisal of semaglutide (TA875)) showed results achieved alongside a reduced-calorie diet and increased physical activity. The medicine works with those changes, not instead of them.

At week 2, with limited appetite suppression so far, a few things are within your control: keeping meals structured rather than reactive, staying hydrated (which genuinely matters as GI side effects are more common when under-hydrated), and logging your starting measurements in a way that doesn't depend on daily scale readings. Waist circumference, how clothes fit, and energy levels are often more informative early signals than weight alone.

Sleep and stress are also relevant. Both affect the hormones that regulate hunger independently of semaglutide, and poor sleep in particular can blunt the appetite-suppressing effect in the short term. None of this means you need to be perfect, but it does mean week 2 is a useful moment to build habits that will compound once the dose rises and the medicine's effects strengthen.

If you're thinking about starting treatment or want to understand more about your options, our free consultation connects you with a GPhC-registered prescriber who can review your situation and answer your specific questions. Speak to our prescribers, that's the right place to take anything this page can't resolve.